Pancreatic Cancer Research

Digest MapAbout

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Wednesday, July 22, 2026

← Previous day Next day →

New paper

RETRACTED: Chen et al. Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci. 2012, 13, 1186-1208.

Why it was picked newest record on or before this date

DOI 10.3390/ijms27146511 ↗ Jul 22, 2026

New paper

Diagnostic Method Advancement to Improve the Prognosis of Pancreatic Ductal Adenocarcinoma.

Why it was picked newest record on or before this date

DOI 10.3390/diagnostics16142286 ↗ Jul 22, 2026

New paper

Adjuvant multimodality immunotherapy in resected high-risk pancreatic ductal adenocarcinoma.

Why it was picked newest record on or before this date

DOI 10.21037/tgh-2026-0046 ↗ Jul 22, 2026

New paper

Reading Between the Voxels: Artificial Intelligence Detection of Occult Pancreatic Cancer.

Why it was picked newest record on or before this date

DOI 10.2214/ajr.26.35577 ↗ Jul 22, 2026

New paper

Reframing pancreatic cancer diagnosis: metabolic signatures and the challenge of rule-out testing.

Why it was picked newest record on or before this date

DOI 10.21037/tgh-2026-0045 ↗ Jul 22, 2026

Also today

New paper

miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.

DOI 10.21037/tcr-2026-0519 ↗ Jul 22, 2026

New paper

Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance.

DOI 10.21037/apc-26-0044 ↗ Jul 22, 2026

New paper

Technical Aspects of Pancreatectomy in the Alliance A021501 Multicenter Clinical Trial of Neoadjuvant Therapy for Pancreatic Cancer: Surgical and Pathologic Documentation.

DOI 10.1200/op-25-01431 ↗ Jul 22, 2026

New paper

Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis.

DOI 10.1016/j.ctarc.2026.101326 ↗

What changed

Change tracking began 4 November 2026, after this day, so only its new records are listed.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

·

Jul 22, 2026

New paper

Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study.

DOI 10.1016/j.bbrc.2026.154332 ↗ Jul 22, 2026